Quofenix 450 mg tablets
- Name:
Quofenix 450 mg tablets
- Company:
A. Menarini Pharmaceuticals Ireland Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 03/12/20

Click on this link to Download PDF directly
A. Menarini Pharmaceuticals Ireland Ltd

Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 3 December 2020 PIL
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Free text change information supplied by the pharmaceutical company
PIL
The changes relate to the requested actions following the PRAC recommendation concerning the signal of “heart valve regurgitation, cervical artery dissection and aortic aneurysm and dissection” associated with Fluoroquinolones intake.
The following sections are updated:
2. What you need to know before you take Quofenix
Warnings and precautions
…Talk to your doctor or pharmacist or nurse before taking Quofenix if:
4. Possible side effects
Updated on 3 December 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 4.8 - Undesirable effects
- Change to section 10 - Date of revision of the text
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
The changes relate to the requested actions following the PRAC recommendation concerning the signal of “heart valve regurgitation, cervical artery dissection and aortic aneurysm and dissection” associated with Fluoroquinolones intake.
The following sections are updated:
Section 4.4 Special warnings and precautions for use
[..]
Aortic dissection and aneurysm, and heart valve regurgitation/incompetence
Further information added.
Section 4.8 Undesirable effects
Cardiac disorders**
Vascular disorders**
** Cases of aortic aneurysm and dissection, sometimes complicated by rupture (including fatal ones), and of regurgitation/incompetence of any of the heart valves have been reported in patients receiving fluoroquinolones (see section 4.4).
Updated on 28 May 2020 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 28 May 2020 PIL
Reasons for updating
- New PIL for new product